GPT and metabolic dysfunction-associated steatotic liver disease: Clinical studies in MASLD patients indicate that quercetin supplementation (500–1000 mg/day) may reduce alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) levels, suggesting its potential therapeutic role [25].